JorgeLHerreraMD

PubMed

• Acquired Immune Deficiency Syndrome Cholangiopathy: Case Series of Three Patients and Literature Review.
  Yasir Ahmed, Mustafeez Ur Rahman, Zoia Ehsan Khattak, Jorge Herrera, Eduardo Calderon> ;Journal of Medical Cases. 2022 Sep 1
• The Liver in Systemic Disease.
  Jorge L. Herrera> ;Clinics in Liver Disease. 2019 May 1
• 8 citations
  Sarcoidosis and the Liver.
  Manoj Kumar, Jorge L. Herrera> ;Clinics in Liver Disease. 2019 Mar 2
• 13 citations
  Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C.
  Mary Caitlin Marshall, Jorge L. Herrera> ;Digestive Diseases and Sciences. 2018 Aug 20
• 5 citations
  Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
  Phillip K. Henderson, Jorge L. Herrera> ;Clinics in Liver Disease. 2015 Aug 1
• 10 citations
  Management of Acute Variceal Bleeding
  Jorge L. Herrera> ;Clinics in Liver Disease. 2014 May 1
• Portal hypertension.
  Jorge L Herrera> ;Clinics in Liver Disease. 2014 May 1
• 7 citations
  Hepatitis B in pregnancy.
  Grant Whittaker, Jorge L. Herrera> ;Southern Medical Journal. 2014 Mar 1
• 24 citations
  The Role of Effective Clinician-Patient Communication in the Management of Irritable Bowel Syndrome and Chronic Constipation
  Jack A. Di Palma, Jorge L. Herrera> ;Journal of Clinical Gastroenterology. 2012 Oct 1
• 11 citations
  Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial.
  Furqaan Ahmed, Ira M. Jacobson, Jorge L. Herrera, Myron H. Brand, Ronald B. Wasserman, Alan M. Fixelle, Vinod K. Rustgi, Clive Albert, Robert S. Brown, Clifford A. Brass> ;Journal of Clinical Gastroenterology. 2011 Mar 1
• 12 citations
  Importance of hepatitis vaccination in patients with chronic liver disease.
  Manoj Kumar, Jorge L. Herrera> ;Southern Medical Journal. 2010 Dec 1
• 34 citations
  A comparison of polyethylene glycol laxative and placebo for relief of constipation from constipating medications.
  Jack A. DiPalma, Mark B. Cleveland, John McGowan, Jorge L. Herrera> ;Southern Medical Journal. 2007 Nov 1
• 2 citations
  PRO: Management of Hepatitis C by Liver Disease Specialists
  Jorge L. Herrera> ;The American Journal of Gastroenterology. 2007 Sep 1
• 55 citations
  A randomized, multicenter comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation
  Jack A. Di Palma, Mark Vb Cleveland, John E. McGowan, Jorge L. Herrera> ;The American Journal of Gastroenterology. 2007 Jun 15
• 128 citations
  A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation.
  Jack A. DiPalma, Mark Vb Cleveland, John McGowan, Jorge L. Herrera> ;The American Journal of Gastroenterology. 2007 Mar 31
• 23 citations
  An open-label study of chronic polyethylene glycol laxative use in chronic constipation.
  J. A. Di Palma, M. Vb. Cleveland, John E. McGowan, Jorge L. Herrera> ;Alimentary Pharmacology & Therapeutics. 2007 Mar 1
• 7 citations
  Medical Care of the Patient With Compensated Cirrhosis.
  Jorge L. Herrera, Reynaldo Rodriguez> ;Gastroenterology & Hepatology. 2006 Feb 1
• 45 citations
  Acetaminophen overdose in pregnancy.
  Jason M. Wilkes, Larry E. Clark, Jorge L. Herrera> ;Southern Medical Journal. 2005 Nov 1
• How much hepatitis B is too much
  Jorge L. Herrera> ;The American Journal of Gastroenterology. 2003 Jun 1
• Finally: changing the natural history of chronic hepatitis C!
  Olaitan A. Adeniji, Jorge L. Herrera> ;The American Journal of Gastroenterology. 2001 Nov 1
• 22 citations
  Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance
  Leland J. Yee, Heidi L. Weiss, Rebecca G Langner, Jorge L. Herrera, Richard A. Kaslow, Dirk J. van Leeuwen> ;BMC Infectious Diseases. 2001 Jul 24
• 100 citations
  Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection.
  Leland J. Yee, Jianming Tang, Jorge L. Herrera, Richard A. Kaslow, D. J. Van Leeuwen> ;Genes and Immunity. 2000 Aug 1
• 26 citations
  Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy
  Jorge L. Herrera> ;The American Journal of Gastroenterology. 1999 Dec 1
• 9 citations
  Immune globulin and vaccine therapy to prevent hepatitis a infection
  Michael J. Levy, Jorge L. Herrera, Jack A. DiPalma> ;The American Journal of Medicine. 1998 Nov 1
• 6 citations
  Management of acute liver failure.
  Jorge L. Herrera> ;Digestive Diseases. 1998 Sep 1
• Join now to see all

Journal Articles

• Lack of Patient Compliance in Real-World Practice Negatively Affects Sustained Viral Response Rates to Direct Acting Agent Therapy for Hepatitis C  
  Jorge Herrera, MD, Digestive Diseases and Sciences

Books/Book Chapters

• Practical Management of Liver Diseases 
  Chapter: Complications of cirrhosis 
  Herrera JLEditors: Z.M. Younossi.Cambridge University Press, New York2008
• GI/Liver Secrets 
  Chapter: Antiviral therapy for hepatitis C infection 
  Smith JR, Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• GI/Liver Secrets 
  Chapter: Antiviral therapy for hepatitis B 
  Herrera JL, Smith JREditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• GI/Liver Secrets 
  Chapter: Liver Abscess 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia2001
• Secrets In Gastroenterology and Hepatology 
  Chapter: Liver Abscess 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia1995
• Secrets In Gastroenterology and Hepatology 
  Chapter: Chronic Diarrhea 
  Herrera JLEditors: P.R. McNally.Hanley and Belfus Inc., Philadelphia1995
• Join now to see all

Abstracts/Posters

• Tolerability and Efficacy of Direct Acting Antiviral Therapy for Hepatitis C in Clinical Practice
  Sbahi H, Henrderson P, Herrera J, 78th Annual Scientific Meeting of the American College of Gastroenterology, San Diego, CA, 10/1/2013
• Tolerability and Efficacy of Direct Acting Antiviral Therapy for Hepatitis C in Clinical Practice
  Sbahi H, Henrderson P, Herrera J, Am J Gastroenterol, 1/1/2013
• A surprising etiology of dysphagia in a patient with known Eosinophilic Esophagitis
  Keller CB, Herrera J, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• Are Patients Who Undergo Treatment for Chronic Hepatitis C (HCV) Vaccinated for Hepatitis A and B?
  Landreneau SW, Voelkel JP, Herrera JL, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• African American and Caucasian American patients with hepatitis C infection choose not to undergo antiviral therapy for similar reasons
  Kakati B, Herrera J, Annual Meeting of the American College of Gastroenterology, San Antonio, TX, 10/1/2010
• African American and Caucasian American patients with hepatitis C infection choose not to undergo antiviral therapy for similar reasons
  Kakati B, Herrera J, Am J Gastroenterol, 1/1/2010
• A surprising etiology of dysphagia in a patient with known Eosinophilic Esophagitis
  Keller CB, Herrera J, Am J Gastroenterol, 1/1/2010
• Are Patients Who Undergo Treatment for Chronic Hepatitis C (HCV) Vaccinated for Hepatitis A and B?
  Landreneau SW, Voelkel JP, Herrera JL, Am J Gastroenterol, 1/1/2010
• Most patients with hepatitis C (HCV) infection choose not to undergo antiviral therapy
  Kakati B, Zhao J, Herrera J, Annual Meeting of the American College of Gastroenterology, San Diego, CA, 10/1/2009
• Most patients with hepatitis C (HCV) infection choose not to undergo antiviral therapy
  Kakati B, Zhao J, Herrera J, Am J Gastroenterol, 1/1/2009
• Is colonoscopy a valid time to screen for diabetes mellitus?
  Herman M, DiPalma J, Herrera J, Am J Gastroenterol, 1/1/2009
• An unusual case of right upper quadrant pain
  Keller CB, Herrera JL, 72nd Annual Scientific Meeting of the American College of Gastroenterology, Philadelphia, PA, 10/1/2007
• A randomized, multi-center comparison of polyethylene glycol laxative and tegaserod in treatment of patients with chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Digestive Disease Week, Washington, DC, 5/1/2007
• A randomized, multi-center, placebo-controlled trial of polyethylene glycol for chronic treatment of chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Digestive Disease Week, Washington, DC, 5/1/2007
• A randomized, multi-center, placebo-controlled trial of polyethylene glycol for chronic treatment of chronic constipation
  DiPalma JA, Cleveland M, McGowan J, Herrera JL, Gastroenterology, 1/1/2007
• The diagnostic yield of a comprehensive metabolic evaluation in patients diagnosed with hepatitis C infection
  Rutland TJ, Voelkel JP, Herrera J, 71st Annual Scientific Meeting of the American College of Gastroenterology, Las Vegas, NV, 10/1/2006
• The diagnostic yield of a comprehensive metabolic evaluation in patients diagnosed with hepatitis C infection
  Rutland TJ, Voelkel JP, Herrera J, Am J Gastroenterol, 1/1/2006
• Acetaminophen overdose in pregnancy: A case report and review of the literature
  Wilkes JM, Herrera JL, 67th Annual Scientific Meeting of the American College of Gastroenterology, Seattle, WA, 1/1/2002
• Acetaminophen overdose in pregnancy: A case report and review of the literature
  Wilkes JM, Herrera JL, Am J Gastroenterol, 1/1/2002
• Only patients with a very low viral load at week 12 may still become sustained responders to interferon/ribavirin combination therapy for chronic hepatitis C infection
  Van Leeuwen DJ, Yee LJ, Herrera JL, Langner RG, 5th Schering Hepatitis Investigator’s Network Meeting, Orlando, FL, 2/1/2001
• Efficacy of interferon alfacon-1 in nonresponders and relapsers to interferon and ribavirin
  Sjogren MH, Wu G, Herrine S, Raufman JP, Bacon B, Epstein M, Medoff J, Chen S, Waters B, Krawitt E, Herrera J, Gastroenterology, 1/1/2000
• Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alpha interferon
  Herrera JL, 49th Annual Meeting of the American Association for the Study of Liver Disease, Chicago, IL, 11/1/1998
• Combination therapy with interferon and ribavirin for chronic hepatitis C patients resistant to alpha interferon
  Herrera JL, Hepatology, 1/1/1998
• Hepatitis C virus (HCV) genotypes: Distribution in a non-tertiary care setting and its relationship to the clinical and histologic characteristics of patients with ch...
  Umana E, Herrera JL, 62nd Annual Scientific Meeting of the American College of Gastroenterology, Chicago, IL, 11/1/1997
• Assessment of HCV RNA and HCV genotypes from 1510 chronic HCV patients treated in community clinical practice in the United States
  Mutchnick M, Tamburro C, Hassanein T, Tong M, Herrera JL, Conrad A, Russell J, Blatt L, 97th Annual Meeting of the American Gastroenterological Association and the American Association for the Study of Liver Diseases, Washington, DC, 5/1/1997
• Join now to see all

Lectures

• Hepatocellular Carcinoma: Surgery, embolization or Drug Therapy – How to tailor treatment to the patient 
  Washington, DC - 4/1/2013
• Evaluation of Liver Lesions 
  Washington, DC - 4/1/2013
• Side effects and management of current HCV therapy 
  Washington, DC - 4/1/2013
• Current Management of Hepatitis B Infection 
  Jackson, MS - 2/1/2013
• Update on hepatitis B management 
  Destin, FL - 1/1/2013
• Update on hepatitis C management 
  Destin, FL - 1/1/2013
• Difficult Hepatitis B infection cases 
  Rochester, NY - 1/1/2012
• Practical management of hepatitis B infection 
  Las Vegas, NV - 1/1/2012
• Complications of hepatitis B infection 
  Miami, FL - 9/1/2011
• 2011 Cutting Edge Hepatology: Translating research into clinical practice 
  Birmingham, AL - 9/1/2011
• Fatty Liver disease 
  Birmingham, AL - 9/1/2011
• Early intervention with TIPS for bleeding esophageal varices 
  Miami, FL - 3/1/2011
• Future directions for finding a cure in hepatitis B 
  Charlottesville, VA - 1/1/2011
• Portal Hypertensive Bleeding 
  Williamsburg, VA - 1/1/2010
• Who and When to Refer for Liver Transplantation 
  Williamsburg, VA - 1/1/2010
• Hepatitis B Infection: Why we care and How to Treat 
  San Diego, CA - 1/1/2009
• Chronic hepatitis B infection 
  Las Vegas, NV - 1/1/2006
• Growth Factors in the Treatment of Chronic Hepatitis C 
  Baltimore, MD - 10/1/2003
• Ascites: Pathophysiology and Management 
  Seattle, WA - 10/1/2002
• Medical Care of the Cirrhotic 
  Las Vegas, NV - 1/1/2001
• Ascites – Learning Luncheon 
  Las Vegas, NV - 1/1/2001
• Viral Hepatitis: Practical Management – PEG Interferons: How to Use Them 
  Las Vegas, NV - 1/1/2001
• Approach to Abnormal Liver Tests 
  Point Clear, AL
• Join now to see all